Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2020-09-15
2023-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The results of this research will allow an improvement in the understanding and management of patients in the medium and long term.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REassessement After Hospitalization for Sars-COV-2 disordER
NCT04443257
Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.
NCT04372979
Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments
NCT05069389
French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study
NCT04340466
COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units
NCT04433325
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient admitted to intensive care unit for COVID-19
Follow-up of patients with COVID-19
The presence of sequelae, number of re-hospitalizations, date of death and cost of health expenditure will be collected.
The Quality of life score (SF-36 questionnaire) and the Pittsburgh sleep quality index (PSQI questionnaire) will be completed by patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow-up of patients with COVID-19
The presence of sequelae, number of re-hospitalizations, date of death and cost of health expenditure will be collected.
The Quality of life score (SF-36 questionnaire) and the Pittsburgh sleep quality index (PSQI questionnaire) will be completed by patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patient ≥ 18 years old
* Subject having expressed his non-opposition to the research
* Subject affiliated to a social health insurance protection scheme or beneficiary of such a scheme
Exclusion Criteria
* Patient under guardianship or curatorship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7883
Identifier Type: OTHER
Identifier Source: secondary_id
TeleRea'nCo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.